★
Trade Filings
Managers Stocks Filings Superinvestors
Signals Institutional Buying Institutional Selling Insider Activity 13D & 13G Watch Sector Rotation
Tools Stock Screener Manager Screener Compare Managers Consensus Baskets All Research Tools Data API
Learn & AI Learn Ask the Data AI Agents
News ★ Saved
About About us Methodology Contact Disclaimer
Reader
DATA PLANS

Historical data downloads — coming with accounts.

API GATEWAY

Free read-only JSON access to the site's cached data.

Dark mode

Guided View
New to markets (prices, yields, YTD, market cap)? We explain every term as you browse, in plain English. Same data, with the help built in.

Expert View
You already know the market. Just the data: clean, fast and compact, with no extra explanations. This is the default view.

Interface language
Security record · archived quarter

TMDX

TransMedics Group, Inc. · Healthcare · Medical - Devices

78.31 +0.2% mkt cap $2.71B quote delayed (FMP) · as of Oct 13 14:08 UTC — separate from filing data below

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024
11Tracked holders
-1Δ holders
3.86MShares held
$259.47MReported value
+2New positions
−3Exits
Falling Conviction score 42/100 2 quarters of rising tracked shares ●●○○○○ How these are computed → Explain this at the Research Desk →

Momentum inputs (comparable managers): holder breadth -8.3% · share flow +6.6% · net new positions -9.1% — formula
Concentrated accumulation — rising shares among fewer holders

All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025

Ownership over time
QuarterHoldersΔSharesReported valueNewExits
Q2 2026 103 -3 25.85M $1.72B +11 −15
Q1 2026 110 -2 27.24M $2.71B +6 −9
Q4 2025 113 -2 29.10M $3.52B +1 −2
Q3 2025 21 +2 20.81M $2.34B +2 −1
Q2 2025 17 +3 18.14M $2.43B +3 —
Q1 2025 11 -1 3.86M $259.47M +2 −3
Q4 2024 12 +2 3.62M $225.65M +3 −1
Q3 2024 9 -4 2.19M $344.12M — −4
Q2 2024 13 — 2.46M $370.15M — —
Holder count
Who holds it · Q1 2025
#ManagerSharesΔ sharesValueTheir weightHeld
1 State Street Global Advisors ✦ (passive) 1.31M -4.0% $87.90M 0.0% ▼ Trim 2 SEC ↗ ×2
2 Geode Capital Management ✦ (passive) 793.41K +2.7% $53.39M 0.0% ▲ Add 4 SEC ↗ ×2
3 Citadel Advisors ✦ 609.69K +161.7% $41.02M 0.0% ▲ Add 2 SEC ↗ ×2
4 Wellington Management ✦ 290.62K +76.7% $19.55M 0.0% ▲ Add 4 SEC ↗ ×5
5 Baillie Gifford ✦ 259.68K -3.8% $17.47M 0.0% ▼ Trim 4 SEC ↗ ×4
6 Capital World Investors ✦ 227.44K New $15.30M 0.0% New 1 SEC ↗
7 Marshall Wace ✦ 152.45K New $10.26M 0.0% New 1 SEC ↗ ×3
8 T. Rowe Price ✦ 135.70K -47.5% $9.13M 0.0% ▼ Trim 4 SEC ↗ ×2
9 Norges Bank ✦ (passive) 40.27K -89.0% $2.71M 0.0% ▼ Trim 4 SEC ↗
10 Two Sigma Investments ✦ 22.70K +81.3% $1.53M 0.0% ▲ Add 2 SEC ↗
11 D. E. Shaw & Co. ✦ 17.91K +147.3% $1.20M 0.0% ▲ Add 2 SEC ↗ ×2

“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.

New buyers

Capital World Investors $15.30M 0.0%
Marshall Wace $10.26M 0.0%

Exited

Millennium Management $10.28M was 0.0%
AQR Capital Management $263,866 was 0.0%
Bridgewater Associates $215,918 was 0.0%

Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 412 holders, 36.17M shares, $3.51B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.

Frequently co-owned

What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.

Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR. Reporting period: Q1 2025 · Methodology · Get this via the API